EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long Non‐Coding RNA IGFRIL Couples with PTBP1 to Destabilize IGFBP3 mRNA to Promote the IGF1R‐AKT‐mTOR Axis and Hepatocellular Carcinoma

Jing Zhang, Chengming Gao, Haibei Li, Yuying Chen, Liting Yang, Qian Jin, Lan Feng, Xia Wang, Xinyi Liu, Hongxia Chen, Rong Ye, Yuanchao Xue und 17 weitere

Advanced Science · 2025-10 · 12 (39)

DOI: 10.1002/advs.202507676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 21.07.2025. Verfasst von Jing Zhang und 28 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medical Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, 100850…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, RNA, Long Noncoding, Polypyrimidine Tract-Binding Protein, Liver Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incomplete understanding of the IGFR pathway activation mechanism limits its clinical application in hepatocellular carcinoma (HCC). Here, a transcriptome‐wide screening is performed and a novel HCC‐associated lncRNA, named IGFR‐inducing lncRNA ( IGFRIL ) is identified. IGFRIL is frequently upregulated in HCC tissues and predicts poor clinical outcomes. It is revealed that IGFRIL plays an oncogenic role in the development of HCC. Mechanistically, IGFRIL serves as a scaffold to recruit PTBP1, destabilizing IGFBP3 mRNA and thereby overactivating the IGF1R‐AKT‐mTOR signaling in HCC cells. Furthermore, it is observed that the inhibitors against IGF1R or mTOR exhibit suppressive effects on patient‐derived tumor xenograft tumors with high IGFRIL expression, through simultaneous blocking of the IGF1R‐AKT‐mTOR signaling pathway. In summary, this study identifies IGFRIL as a novel non‐coding activator of the IGF1R pathway, providing a promising new therapeutic target for HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularRNA, Long NoncodingPolypyrimidine Tract-Binding ProteinLiver NeoplasmsHeterogeneous-Nuclear RibonucleoproteinsInsulin-Like Growth Factor Binding Protein 3HumansTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionAnimalsMiceCell Line, TumorReceptor, IGF Type 1RNA, MessengerGene Expression Regulation, NeoplasticMale

Stichwörter der Autor:innen

IGF1R‐AKT‐mTOR signalingIGFBP3PTBP1hepatocellular carcinoma (HCC)long non‐coding RNA IGFRIL

Substanzen

RNA, Long NoncodingTOR Serine-Threonine KinasesPolypyrimidine Tract-Binding ProteinProto-Oncogene Proteins c-aktMTOR protein, humanPTBP1 protein, humanHeterogeneous-Nuclear RibonucleoproteinsInsulin-Like Growth Factor Binding Protein 3IGF1R protein, humanIGFBP3 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Medical Proteomics, National Center for Protein Sciences at Beijing, Beijing Institute of Radiation Medicine, Beijing, 100850, China.
  • Institute of Life Science and Green Development, College of Life Sciences, Hebei University, Baoding City, Hebei Province, 071000, China.
  • Department of Environment and Health, Military Medical Sciences Academy, Tianjin, 300132, China.
  • Hengyang Medical School, University of South China, Hengyang City, Hunan Province, 421001, China.
  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha City, Hunan Province, 410008, China.
  • Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical College, Xuzhou City, Jiangsu Province, 221006, China.

ORCID-Profile: Gangqiao Zhou

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, J., Gao, C., Li, H., Chen, Y., Yang, L., Jin, Q., Feng, L., Wang, X., Liu, X., Chen, H., Ye, R., Xue, Y., Wang, H., Zeng, M., Yang, M., Ju, H., Gao, C., Zhou, G., Zhang, Q., …, & Zhou, G. (2025). Long Non‐Coding RNA IGFRIL Couples with PTBP1 to Destabilize IGFBP3 mRNA to Promote the IGF1R‐AKT‐mTOR Axis and Hepatocellular Carcinoma. Advanced Science, 12(39). https://doi.org/10.1002/advs.202507676

Vancouver

Zhang J, Gao C, Li H, Chen Y, Yang L, Jin Q, et al. Long Non‐Coding RNA IGFRIL Couples with PTBP1 to Destabilize IGFBP3 mRNA to Promote the IGF1R‐AKT‐mTOR Axis and Hepatocellular Carcinoma. Advanced Science. 2025;12(39). doi:10.1002/advs.202507676

BibTeX
@article{Zhang2025,
  author = {Zhang, Jing and Gao, Chengming and Li, Haibei and Chen, Yuying and Yang, Liting and Jin, Qian and Feng, Lan and Wang, Xia and Liu, Xinyi and Chen, Hongxia and Ye, Rong and Xue, Yuanchao and Wang, Huiyun and Zeng, Musheng and Yang, Ming and Ju, Huaiqiang and Gao, Chengzhi and Zhou, Guangming and Zhang, Qi and Zhang, Qian and Qin, Geng and Li, Yuanfeng and Wang, Yahui and Yang, Aiqing and Si, Anfeng and Song, Qingfeng and He, Fuchu and Cao, Pengbo and Zhou, Gangqiao},
  title = {Long Non‐Coding RNA IGFRIL Couples with PTBP1 to Destabilize IGFBP3 mRNA to Promote the IGF1R‐AKT‐mTOR Axis and Hepatocellular Carcinoma},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {39},
  doi = {10.1002/advs.202507676}
}
Kostenlos starten →